Correlation of 18F-BPA and 18F-FDG uptake in head and neck cancers
- 1 November 2014
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 113 (2) , 193-197
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Evaluation of performance of an accelerator-based BNCT facility for the treatment of different tumor targetsPhysica Medica, 2013
- Predominant contribution of L-type amino acid transporter to 4-borono-2-18F-fluoro-phenylalanine uptake in human glioblastoma cellsNuclear Medicine and Biology, 2013
- Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancerRadiation Oncology, 2012
- Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)Radiotherapy and Oncology, 2012
- Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head-and-Neck Cancer: Final Analysis of a Phase I/II TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- BNCT for locally recurrent head and neck cancer: Preliminary clinical experience from a phase I/II trial at Tsing Hua Open-Pool ReactorApplied Radiation and Isotopes, 2011
- Boron neutron capture therapy (BNCT) followed by intensity modulated chemoradiotherapy as primary treatment of large head and neck cancer with intracranial involvementRadiotherapy and Oncology, 2011
- BNCT for skin melanoma in extremities: Updated Argentine clinical resultsApplied Radiation and Isotopes, 2009
- Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)Radiotherapy and Oncology, 2008
- 4-Borono-2-[18F]fluoro-d,l-phenylalanine as a target compound for boron neutron capture therapy: Tumor imaging potential with positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991